Literature DB >> 10445617

NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.

J Mattes1, K Storm van's Gravesande, U Reining, K Alving, G Ihorst, M Henschen, J Kuehr.   

Abstract

The relationship between nitric oxide in exhaled air, levels of sputum eosinophils, sputum eosinophil cationic protein (ECP) and urinary eosinophil protein X (EPX) excretion has not yet been investigated in corticosteroid-dependent childhood asthma. Therefore, taking 25 children with stable asthma (mean age 11.2 yrs) treated with inhaled corticosteroids and nine nonatopic healthy control children (mean age 12.8 yrs) the level of exhaled NO was measured by means of a chemiluminescence analyser before and after sputum induction. This was conducted as a slow vital capacity manoeuvre under standardized conditions with a target flow of 70 mL x s(-1) against a resistance of 100 cm H2O x L(-1) x s. Sputum induction was performed by inhalation of hypertonic saline (3, 4, and 5%) in a standardized manner and a single sample of urine was collected. Exhaled NO (p = 0.01), absolute eosinophil cell counts in sputum (p = 0.02), sputum ECP (p = 0.09) and urinary EPX excretion (p = 0.02) were higher in asthmatics compared to control children. Exhaled NO was positively correlated with sputum ECP (r(s) = 0.59, p = 0.002), urinary EPX (r(s) = 0.42, p = 0.03), and sputum eosinophils (r(s) = 0.30, p = 0.15) in the asthmatic children. These correlations appeared to be pronounced after sputum induction, where NO values had decreased (p = 0.01). None of the correlations were observed in the group of nonatopic control subjects. Additionally there were significant correlations between sputum ECP and sputum eosinophils (r(s) = 0.69, p<0.001) as well as between sputum ECP and urinary EPX excretion (r(s) = 0.58, p = 0.003) in the asthmatics. Exhaled NO provides information about the degree of eosinophilic airway inflammation and thus appears to be a useful and easy-to-perform inflammatory marker in corticosteroid-dependent asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445617

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma.

Authors:  Jiangtao Lin; Kaisheng Yin; Nan Su; Mao Huang; Chen Qiu; Chuntao Liu; Shaoxi Cai; Chuangli Hao
Journal:  Ann Transl Med       Date:  2015-11

Review 2.  Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma.

Authors:  Jiangtao Lin; Kaisheng Yin; Nan Su; Mao Huang; Chen Qiu; Chuntao Liu; Shaoxi Cai; Chuangli Hao
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

3.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

Authors:  Raed A Dweik; Ronald L Sorkness; Sally Wenzel; Jeffrey Hammel; Douglas Curran-Everett; Suzy A A Comhair; Eugene Bleecker; William Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Elliot Israel; Nizar Jarjour; Wendy Moore; Stephen Peters; Gerald Teague; Benjamin Gaston; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

4.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

5.  Evidence for different subgroups of difficult asthma in children.

Authors:  D N Payne; N M Wilson; A James; H Hablas; C Agrafioti; A Bush
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

Review 6.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

7.  Exhaled nitric oxide and urinary EPX levels in infants: a pilot study.

Authors:  Fredrik Carlstedt; Dagmara Lazowska; Carl-Gustaf Bornehag; Anna-Carin Olin; Mikael Hasselgren
Journal:  Clin Mol Allergy       Date:  2011-05-16

Review 8.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 9.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

10.  Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.

Authors:  Rebecca S Gruchalla; Hugh A Sampson; Elizabeth Matsui; Gloria David; Peter J Gergen; Agustin Calatroni; Mark Brown; Andrew H Liu; Gordon R Bloomberg; James F Chmiel; Rajesh Kumar; Carin Lamm; Ernestine Smartt; Christine A Sorkness; Suzanne F Steinbach; Kelly D Stone; Stanley J Szefler; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2009-07-16       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.